Eledon Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELDN and other ETFs, options, and stocks.About ELDN
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease. The firm’s compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential.
CEODavid-Alexandre C. Gros
CEODavid-Alexandre C. Gros
Employees20
Employees20
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2004
Founded2004
Employees20
Employees20
ELDN Key Statistics
Market cap48.88M
Market cap48.88M
Price-Earnings ratio-1.07
Price-Earnings ratio-1.07
Dividend yield—
Dividend yield—
Average volume162.40K
Average volume162.40K
High today$2.09
High today$2.09
Low today$1.91
Low today$1.91
Open price$1.97
Open price$1.97
Volume67.36K
Volume67.36K
52 Week high$2.95
52 Week high$2.95
52 Week low$1.07
52 Week low$1.07